Yatharth Hospital & Trauma Care Services Limited — PPTs, 05-08-2025: Investor Presentation

**Financial Highlights:**

Yatharth Hospitals' Q1 FY26 revenue rose 22% YoY to Rs 257.8 Cr. PAT soared 40% YoY to Rs 42.5 Cr (16.5% margin), and EBITDA grew 20% to Rs 64.5 Cr. Operational metrics saw improvement with occupancy reaching 65% and Average Revenue Per Occupied Bed (ARPOB) increasing 6% to Rs 32,395.

**Strategic Initiatives & Growth Drivers:**

The company is significantly expanding capacity, adding ~700 beds with new New Delhi (300 beds, operational July 2025) and Greater Faridabad (400 beds, operational August 2025) facilities. Strategic focus on high-value specialties like Oncology and Medical Value Travel partnerships aims to boost ARPOB and future growth.

**Business Developments:**

Notably, the Greater Faridabad hospital turned profitable within its first year of operations. Recent acquisitions, including Model Town Hospital in Delhi and a new hospital in Faridabad, significantly expand the regional footprint. A long-standing land dispute concerning Ramraja Hospital has also been favorably resolved.

**Market Position & Competitive Advantage:**

Operating 7 hospitals and 11 Centers of Excellence, Yatharth solidifies its position as a leading super-specialty healthcare provider in North India. JCI accreditation for its Noida Extension facility underscores its commitment to quality and enhances its competitive edge.

**Investor Implications:**

Robust financial growth coupled with substantial capacity additions from recently operationalized facilities suggest strong positive growth potential. The focus on high-margin services and efficient integration of new assets are key drivers to monitor.